Sort
1,049,261 grants matching “t cell”
North Central Cancer Treatment Group
$2,543,699Jan C Buckner · Mayo Clinic Rochester · U10 · FY2007 · CA
Genetic analysis of type II diabetes in Finnish population
$2,543,663Francis Sellers Collins · National Human Genome Research Institute · ZIA · FY2012 · HG
Novel Therapies to Improve Renal and Cardiac Allograft Outcomes
$2,543,579Anil K Chandraker · Brigham And Women'S Hospital · U01 · FY2013 · AI
Novel Mechanisms of Protein Homeostasis by the Molecular Chaperone DnaK
$2,543,522Eduardo A. Groisman · Yale University · R01 · FY2025 · AI
Protein Glycosylation in the Coagulopathy and Inflammation of Sepsis
$2,543,485Jamey Marth · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2019 · HL
Protein Glycosylation in the Coagulopathy and Inflammation of Sepsis
$2,543,485Jamey Marth · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2020 · HL
Carbohydrate-based Therapy for Lung Disease
$2,543,475John V Fahy · University Of California, San Francisco · P01 · FY2020 · HL
Cytokine Signaling, Immunoregulation and Autoimmune and Immunodeficiency Diseases
$2,543,374John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2024 · AR
Genetic analysis of type II diabetes in Finnish population
$2,543,269Francis Sellers Collins · National Human Genome Research Institute · ZIA · FY2014 · HG
DF/HCC Kidney Cancer SPORE
$2,543,224David McDermott · Beth Israel Deaconess Medical Center · P50 · FY2020 · CA
Genomics Core Facility
$2,543,191John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2014 · DK
Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers
$2,543,097Mary E. Choi · Weill Medical Coll Of Cornell Univ · P01 · FY2025 · HL
Pathology Peer Review and Pathology Support for the DNTP and DIR at NIEHS (EPL)
$2,543,000Rodney Miller · Experimental Pathology Laboratories · N01 · FY2023 · ES
Toward Safer Gene Therapy for Hemophilia A
$2,542,930Roland W. Herzog · Indiana University Indianapolis · P01 · FY2025 · HL
Toward Safer Gene Therapy for Hemophilia A
$2,542,930Roland W. Herzog · Indiana University Indianapolis · P01 · FY2023 · HL
Multiethnic Study of Type 2 Diabetes Genes
$2,542,751David Altshuler · Broad Institute, Inc. · U01 · FY2010 · DK
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria
$2,542,664James C Sacchettini · Texas A&M Agrilife Research · P01 · FY2018 · AI
INTEGRINS AND MODULAR SURFACE PROTEINS IN VASCULATURE
$2,542,576Timothy A Springer · Immune Disease Institute, Inc. · P01 · FY2006 · HL
Novel Strategy to Induce Islet Protective Regulatory T Cells and Prevent Diabetes
$2,542,500Brian D Brown · Icahn School Of Medicine At Mount Sinai · DP2 · FY2008 · DK
Dissecting tumor metabolic heterogeneity in vivo
$2,542,500Kivanc Birsoy · Rockefeller University · DP2 · FY2017 · CA
Defining the role of chromatin architecture in cell fate inheritance
$2,542,500Effie Apostolou · Weill Medical Coll Of Cornell Univ · DP2 · FY2016 · DA
Sensory Neuron-Bacteria Interactions in Modulating Pain and the Host Microbiota
$2,542,500Isaac Ming-Cheng Chiu · Harvard Medical School · DP2 · FY2016 · AT
Cognate microglia-neuron interaction and its role in inflammation
$2,542,500Anne Schaefer · Icahn School Of Medicine At Mount Sinai · DP2 · FY2012 · MH
Shapeshifters in Cancer: Defining the Fundamental Forces of Leukemia Evolution
$2,542,500Dan Landau · Weill Medical Coll Of Cornell Univ · DP2 · FY2018 · CA
A novel framework for the functional dissection of motor systems
$2,542,500Nicolas Xavier Tritsch · New York University School Of Medicine · DP2 · FY2017 · NS